Search

Displaying results 4631 - 4640 of 8517 in total
  1. Drug

    Nipocalimab

    go.drugbank.com/drugs/DB16257
    ApprovedInvestigational

    [L64042] Nipocalimab-aahu was first approved by the FDA in April 2025 for generalized myasthenia gravis.

  2. Drug

    Romiplostim

    go.drugbank.com/drugs/DB05332
    ApprovedInvestigational

    The peptibody molecule has two identical single-chain subunits, each one is made up of 269 amino acid residues.

  3. Drug

    Etretinate

    go.drugbank.com/drugs/DB00926
    ApprovedWithdrawn

    Etretinate was taken off the market in Canada in 1996 and America in 1998 due to the risk of birth defects. Etretinate is now used to treat T-cell lymphomas.

  4. Drug

    Tamsulosin

    go.drugbank.com/drugs/DB00706
    ApprovedInvestigational

    [A178351] Tamsulosin was first approved by the FDA on April 15, 1997.[L6238]

  5. Drug

    ASP-4058

    go.drugbank.com/drugs/DB11819
    Investigational

    ASP4058 has been used in trials studying Food Effect of ASP4058 and Pharmacokinetics of ASP4058.

  6. Drug

    Pritelivir

    go.drugbank.com/drugs/DB11844
    Investigational

    Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.

  7. Drug

    gp209-2M antigen

    go.drugbank.com/drugs/DB17462
    Investigational

    The gp209-2M antigen is derived from gp209, and has potential immunomodulatory and antineoplastic activities.

  8. Drug

    Glial growth factor 2

    go.drugbank.com/drugs/DB12841
    Investigational

    Glial growth factor 2 has been used in trials studying the treatment of Heart Failure.

  9. Drug

    Calcitonin eel

    go.drugbank.com/drugs/DB12898
    Investigational

    HC-58 has been used in trials studying the prevention of Severe Upper Limb Hemiplegia.

  10. Drug

    Nikkomycin Z

    go.drugbank.com/drugs/DB12939
    Investigational

    Nikkomycin Z has been used in trials studying the treatment and basic science of Coccidioidomycosis.